Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Return on public health investment: CDC's Expanded HIV Testing Initiative.

Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):281-6. doi: 10.1097/QAI.0b013e31823e5bee.

PMID:
22067662
4.
5.

Results of the Expanded HIV Testing Initiative--25 jurisdictions, United States, 2007-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jun 24;60(24):805-10.

6.
7.

Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.

Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S133-8.

PMID:
9663636
8.

Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis.

Holtgrave DR, Valdiserri RO, Gerber AR, Hinman AR.

Arch Intern Med. 1993 May 24;153(10):1225-30.

PMID:
8388208
9.

Economic implications of failure to reduce incident HIV infections by 50% by 2005 in the United States.

Holtgrave DR, Pinkerton SD.

J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):171-4.

PMID:
12794550
10.
11.

HIV incidence and CDC's HIV prevention budget: an exploratory correlational analysis.

Holtgrave DR, Kates J.

Am J Prev Med. 2007 Jan;32(1):63-7. Epub 2006 Dec 20.

PMID:
17184960
12.

Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

Pinkerton SD, Holtgrave DR, Pinkerton HJ.

Arch Intern Med. 1997 Sep 22;157(17):1972-80.

PMID:
9308509
13.

Use of social networks to identify persons with undiagnosed HIV infection--seven U.S. cities, October 2003-September 2004.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2005 Jun 24;54(24):601-5.

14.
15.
16.

Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC.

Castel AD, Choi S, Dor A, Skillicorn J, Peterson J, Rocha N, Kharfen M.

PLoS One. 2015 Oct 14;10(10):e0139605. doi: 10.1371/journal.pone.0139605. eCollection 2015.

17.

Cost comparison of three HIV counseling and testing technologies.

Ekwueme DU, Pinkerton SD, Holtgrave DR, Branson BM.

Am J Prev Med. 2003 Aug;25(2):112-21.

PMID:
12880878
18.

A cost-benefit analysis of voluntary routine HIV-antibody testing for hospital patients.

La Croix SJ, Russo G.

Soc Sci Med. 1996 May;42(9):1259-72.

PMID:
8733196
19.

Who should be screened for HIV infection? A cost-effectiveness analysis.

McCarthy BD, Wong JB, Muñoz A, Sonnenberg FA.

Arch Intern Med. 1993 May 10;153(9):1107-16.

PMID:
8481077
20.

Utilization of HIV voluntary counseling and testing in Vietnam: an evaluation of 5 years of routine program data for national response.

Hong NT, Wolfe MI, Dat TT, McFarland DA, Kamb ML, Thang NT, Thai HN, Del Rio C.

AIDS Educ Prev. 2011 Jun;23(3 Suppl):30-48. doi: 10.1521/aeap.2011.23.3_supp.30. Erratum in: AIDS Educ Prev. 2012 Feb;24(1):89. Lamb, Mary L [corrected to Kamb, Mary L].

PMID:
21689035

Supplemental Content

Support Center